Prostate Cancer Clinical Trial

Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population

Summary

The goal of the study is to provide a detailed description of treatments for CRPC (Castrate Resistant Prostate Cancer) patients with bone metastases and the resource utilization and costs associated with that diagnosis and subsequent treatments.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

First diagnosis for bone metastases for members diagnosed with prostate cancer found in the claims data during the identification period
Members age ≥ 55 to 89 years at index
Medicare members with medical and pharmacy coverage; and
Continuously enrolled during the pre- and post-index periods.

Exclusion Criteria:

Member with diagnosis of any other cancer (excluding melanoma (ICD-9 172.x) and other metastases (ICD-9 198.x)) before the index date; and
Members age ≥ 89 years of age at index date

Study is for people with:

Prostate Cancer

Estimated Enrollment:

1163

Study ID:

NCT02518698

Recruitment Status:

Completed

Sponsor:

Bayer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


Louisville Kentucky, , United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

1163

Study ID:

NCT02518698

Recruitment Status:

Completed

Sponsor:


Bayer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider